×
Back to Agenda
Session 3: Impact of PK-PD Modelling and Simulation on Drug Development and Approval
Session Chair(s)
Dong-Seok Yim
Catholic Univ. , United States
Speaker(s)
Regulatory Impact of Pharmacometrics
Jee Eun Lee, PhD
GC Pharma, Korea, Republic of
Head of Research and Early Development
Application of Modeling & Simulation in Clinical Drug Development: Case Studies
Holly Kimko
Astra Zeneca, United States
Research Fellow
PK-PD model based drug development experienced in Korea
Hyeong-Seok Lim
Asan Medical Centre Ulsan University, Korea, Republic of
Have an account?